HomeASND • NASDAQ
Ascendis Pharma A/S
add
$157.54
0.22%
After Hours:(0.00%)0.00
$157.54
Closed: May 15, 5:20:00 PM UTC-4 · USD · NASDAQ · Disclaimer
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (EUR) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 100.95M | 5.28% |
Operating expense | 187.65M | 36.50% |
Net income | -94.63M | 27.79% |
Net profit margin | -93.73 | 31.41% |
Earnings per share | -1.58 | 31.30% |
EBITDA | -99.67M | -123.13% |
Effective tax rate | -1.13% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (EUR) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 517.92M | 61.73% |
Total assets | 1.06B | 32.27% |
Total liabilities | 1.25B | 20.23% |
Total equity | -189.81M | — |
Shares outstanding | 60.37M | — |
Price to book | -50.06 | — |
Return on assets | -23.25% | — |
Return on capital | -37.00% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (EUR) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -94.63M | 27.79% |
Cash from operations | -14.31M | 85.91% |
Cash from investing | -703.00K | -109.83% |
Cash from financing | -18.02M | -197.83% |
Net change in cash | -41.62M | 42.13% |
Free cash flow | 13.25M | 124.71% |
Previous close
$157.20
Day range
$150.89 - $159.03
Year range
$111.09 - $183.00
Market cap
9.51B USD
Avg Volume
590.96K
Primary exchange
NASDAQ
About
Founded
2006
Website
Employees
1,017
